Telmidip 80/5 Tablet

Initial Therapy: Patient may be Initiated on Telmidip Tablets if it is Unlikely that Control of Blood Pressure would be Achieved with a Single Agent. The Usual Starting Dose is 40/5 mg Once Daily. Patients Requiring Larger Blood Pressure Reductions may be Started with 80/5 mg Once Daily. Initial Therapy with Telmidip is not Recommended in Patients ?75 Years Old or with Hepatic Impairment.
Add-on Therapy: Patients not Adequately Controlled with Amlodipine (or Another Dihydropyridine Calcium Channel
Blocker) Alone or with Telmisartan (or Another Angiotensin Receptor Blocker) Alone. Patients Treated with 10 mg Amlodipine who Experience Adverse Reactions such as Edema, may be Switched to Telmidip 40/5 mg Tablets Once Daily, Reducing the Dose of Amlodipine without Reducing the Overall Expected Antihypertensive Response.
Replacement Therapy: Patients Receiving Amlodipine and Telmisartan from Separate Tablets may Instead Receive Telmidip Tablets Containing the Same Component Doses Once daily. Dosage must be Individualized and may be Increased After at Least 2 Weeks. The Maximum Recommended Dose of Telmidip Tablet is 80/10 mg Once Daily.